| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/07/2002 | CA2454601A1 Microparticle protection of therapeutic agents |
| 11/07/2002 | CA2448607A1 Colloidal metal compositions and methods |
| 11/07/2002 | CA2446491A1 Compositions including vitamin-based surfactants ad methods for using same |
| 11/07/2002 | CA2446083A1 Composition and methods for treatment of hyperplasia |
| 11/07/2002 | CA2446052A1 Compositions and methods for treating vulvovaginitis and vaginosis |
| 11/07/2002 | CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production |
| 11/07/2002 | CA2445866A1 Contoured tablets with coloured patterns and preparation thereof via electrostatic deposition |
| 11/07/2002 | CA2445860A1 Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
| 11/07/2002 | CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 11/07/2002 | CA2445826A1 Treatment and diagnosis of macrophage mediated disease |
| 11/07/2002 | CA2445763A1 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| 11/07/2002 | CA2445702A1 Control of compactability through crystallization |
| 11/07/2002 | CA2445584A1 Injectable pamidronate disodium |
| 11/07/2002 | CA2445373A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatitis b viruses |
| 11/07/2002 | CA2445310A1 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 11/07/2002 | CA2445290A1 A pharmaceutical tablet having a high api content |
| 11/07/2002 | CA2445281A1 Prevention of myocardial infarction induced ventricular expansion and remodeling |
| 11/07/2002 | CA2445120A1 Devices for the intradermal administration of influenza vaccines |
| 11/07/2002 | CA2444727A1 Agents for preventing postoperative recurrence of premenopausal breast cancer |
| 11/07/2002 | CA2443381A1 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 11/07/2002 | CA2406552A1 Release of lipophilic active agents from chewing gum |
| 11/06/2002 | EP1254944A1 Dry compositions containing hydrophobic amino acid |
| 11/06/2002 | EP1254935A2 Gelatins with good slipping properties, processes for their preparation and their uses |
| 11/06/2002 | EP1254666A1 Stable antibody compositions and injection preparations |
| 11/06/2002 | EP1254659A1 Stable emulsion compositions |
| 11/06/2002 | EP1254657A2 Liposomes |
| 11/06/2002 | EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 11/06/2002 | EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 11/06/2002 | EP1254146A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 11/06/2002 | EP1254145A1 N,o-amidomalonate platinum complexes |
| 11/06/2002 | EP1254143A2 Lipid-based drug delivery systems |
| 11/06/2002 | EP1254112A2 Ocular hypotensive lipids |
| 11/06/2002 | EP1253957A1 Implantable, refillable infusion device and septum replacement kit |
| 11/06/2002 | EP1253944A2 Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent |
| 11/06/2002 | EP1253937A2 Methods of therapy with thrombin derived peptides |
| 11/06/2002 | EP1253936A2 Microencapsulation and sustained release of biologically active agent |
| 11/06/2002 | EP1253932A2 Botulinum toxin pharmaceutical compositions |
| 11/06/2002 | EP1253918A2 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 11/06/2002 | EP1253913A1 Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups |
| 11/06/2002 | EP1253912A1 Apparatus for providing a red blood cell carrier |
| 11/06/2002 | EP1253911A1 Method for loading a red blood cell with an agent |
| 11/06/2002 | EP1253910A1 Combined diffusion/osmotic pumping drug delivery system |
| 11/06/2002 | EP1253909A2 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 11/06/2002 | EP1253908A2 Pharmaceutical composition for pulmonary delivery |
| 11/06/2002 | EP1253903A2 Surfactant free topical compositions and method for rapid preparation thereof |
| 11/06/2002 | EP1253894A1 Methods and devices for preventing transmission of sexually transmitted diseases |
| 11/06/2002 | EP1253824A2 Fluid insecticidal formulations for treatment of parasitic insect larvae by dermal application |
| 11/06/2002 | EP1169118B1 Method for coating and film-coating fine powders in a fluidised bed coating unit |
| 11/06/2002 | EP1107731B1 Synthetic tear fluid |
| 11/06/2002 | EP1037622A4 Taurine derivatives usable in the treatment of ophthalmic disorders |
| 11/06/2002 | EP0981327B1 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 11/06/2002 | EP0951287B1 Oral composition comprising 5-aminosalicyclic acid |
| 11/06/2002 | EP0918799B1 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems |
| 11/06/2002 | EP0883624B1 Tetraether lipids and liposomes containing said lipids, and use of the same |
| 11/06/2002 | EP0865297B1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 11/06/2002 | EP0843558B1 Composition for enhanced uptake of polar drugs from the colon |
| 11/06/2002 | EP0781150B1 Enhanced transdermal transport using ultrasound |
| 11/06/2002 | EP0777467B1 Aerosol drug formulations containing polyglycolyzed glycerides |
| 11/06/2002 | EP0767632B1 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof |
| 11/06/2002 | EP0746307B1 Cosmetic compositions |
| 11/06/2002 | EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 11/06/2002 | EP0717618B1 Stabilized tablet formulation |
| 11/06/2002 | CN1378554A Novel fusidic acid derivatives |
| 11/06/2002 | CN1378550A Partial or full A1 agonists-N6 heterocyclic 5' thio substituted adenosine devivatives |
| 11/06/2002 | CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery |
| 11/06/2002 | CN1378499A Injection molding method for neutral and acidic-group containing (meth) acrylate copolymers |
| 11/06/2002 | CN1378497A Water unstable foam composition |
| 11/06/2002 | CN1378471A Dual adhesive transdermal drug delivery system |
| 11/06/2002 | CN1378457A Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 11/06/2002 | CN1378452A Orally disintegrating composition containing mirtazapine |
| 11/06/2002 | CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 11/06/2002 | CN1378445A Drug releasing biodegradable fiber implant |
| 11/06/2002 | CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 11/06/2002 | CN1377889A Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid |
| 11/06/2002 | CN1377880A Compound for curing vascular complication, its preparing method and treating use |
| 11/06/2002 | CN1377707A Medicinal composition for target direction transport curing cancer and its usage |
| 11/06/2002 | CN1377706A Ocular in-situ gel preparatino with proper phase conversion temperature |
| 11/06/2002 | CN1377705A Throat moistening carase tablet (sugar) |
| 11/06/2002 | CN1377699A Nano aloe and its preparing method and use |
| 11/06/2002 | CN1377698A Nano woman's cleaning and nursing aloe lotion and its preparing method |
| 11/06/2002 | CN1377689A Traditional Chinese medicine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method |
| 11/06/2002 | CN1377682A Bone-setting pain stopping paste |
| 11/06/2002 | CN1377679A Traditional Chinese medicine particulate preparation for curing cardiovascular and cerebrovascular diseases and its preparing method |
| 11/06/2002 | CN1377678A Traditional Chinese medicine particulate preparation for curing cardiovascular and cerebrovascular diseases and its preparing method |
| 11/06/2002 | CN1377671A Fat reducing Chinese tree frog soft capsule |
| 11/06/2002 | CN1377667A Plaster for curing trachitis and its preparing method |
| 11/06/2002 | CN1377653A Medical paste for burn |
| 11/06/2002 | CN1377645A Tea polyphenol buccal tablet for preventing and curing tooth decay and its preparing method |
| 11/06/2002 | CN1377640A External preparatino for skin |
| 11/06/2002 | CN1377639A Method for wrapping kmedicine by liposome |
| 11/06/2002 | CN1093855C New compsn. containing acid-labile benzimidazole and process for its prepn. |
| 11/06/2002 | CN1093762C Aqueous suspension of 9-hydroxyrisperidone fatty and esters |
| 11/06/2002 | CN1093758C Sustained-released granular preparation and process for producing the same |
| 11/06/2002 | CN1093755C Topical composition for inhibiting hair growth |
| 11/05/2002 | US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 11/05/2002 | US6476243 Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 11/05/2002 | US6476214 Inhibition of cytokine production |
| 11/05/2002 | US6476204 Dextran-maleic acid monoesters and hydrogels based thereon |
| 11/05/2002 | US6476201 Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 11/05/2002 | US6476197 Polypeptides having interferon-γ inducing activity |